China biopharmaceutical: second generation highly selective P2X3 inhibitor approved clinical trial

IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives

In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow

Vietnam's E-Commerce Market Expected to Reach $45 Billion by 2025

Vietnam’s e-commerce growth has ranked among the top ten fastest-growing e-commerce markets globally, with a market size of $20.5 billion in 2023 and an economic scale of $30 billion, placing it among Southeast Asia's top three. By 2025, the e-commerce market is projected to expand to $45 billion.

15th National Assembly’s 8th Session: Strictly Regulating Notarized Transactions to Ensure

As part of the framework of the 15th National Assembly’s 8th session, on the afternoon of November 26, 450 out of 453 delegates voted in favor of passing the Law on Notarization (Amendment). This law consists of 8 chapters and 76 articles and will come into effect on July 1, 2025.

Brazil freezes 5 billion reais in budget spending to curb fiscal deficit.

CTTQ, Ampsourcebio Ink Agreement on Cure for NASH, T2DM

There are more than 95 plus major players and more than 90 plus nonalcoholic steatohepatitis (NASH) pipeline therapies, but none of them has been approved for marketing. Who would survive the competition in the blue-ocean market for NASH?